Rheological Functions of Erythrocyte in ESRD
Recruiting now
Conditions studied: End-stage Renal Disease (ESRD)
In brief
End-stage renal disease (ESRD) disrupts erythrocyte deformability due to osmotic imbalances, oxidative stress, and uremic toxins, leading to impaired microcirculation and oxygen transport. Dysregulation of ion channels, particularly the Gardos channel, exacerbates dehydration and eryptosis, further compromising vascular integrity. Given the critical role of erythrocyte flexibility in oxygen delivery, this study investigates its relationship with aerobic capacity in ESRD patients, highlighting potential mechanisms of microvascular dysfunction
Key facts
- Study ID
- NCT06868888
- Run by
- Chang Gung Memorial Hospital
- People needed
- 40
- Starts
- 2022-08-24
- Expected to finish
- 2025-03-26
- Last updated by the study team
- 2025-03-11
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Receiving hemodialysis and medication at least for 6 weeks
- Kt/V score > 1.2
You may not qualify if…
- Under 20 years-old
- Hyperkalemia occurs within 3 month
- Having orthopedic or muscular diseases
- Other concerned medical, psychological or physiological diseases
- Pregnancy
- Other exercise contraindications
Where it is running
- Chang Gung University — Taoyuan, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.